BRIEF-Brokerage Giant Compass Agrees To Acquire Rival Anywhere For $1.6 Billion

BRIEF-Brokerage Giant Compass Agrees To Acquire Rival Anywhere For $1.6 Billion - WSJ

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Brokerage Giant Compass Agrees To Acquire Rival Anywhere For $1.6 Billion - WSJ

Sep 22, 2025 4:10 AM

Sept 22 (Reuters) -

* BROKERAGE GIANT COMPASS AGREES TO ACQUIRE RIVAL ANYWHERE

FOR

$1.6 BILLION - WSJ

* COMPASS IS VALUING ANYWHERE SHARES AT $13.01 APIECE IN THE

STOCK

SWAP - WSJ

Source text: [https://tinyurl.com/46u8az2w]

Further company coverage:

Previous page： Zomedica Pharmaceuticals Gets CE Mark for Truforma Platform to Expand in Europe Next page： Gogoro Gets $50 Million Investment From Castrol

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Zomedica Pharmaceuticals Gets CE Mark for Truforma Platform to Expand in Europe

Jun 25, 2024

10:33 AM EDT, 06/25/2024 (MT Newswires) -- Zomedica Pharmaceuticals (ZOM) said Tuesday it secured the CE mark for its point-of-care Truforma Bulk Acoustic Wave diagnostic platform to expand in Europe. The veterinary diagnostics platform provides quick, accurate results at the point of care in minutes, the company said. Shares of Zomedica Pharmaceuticals rose 4.1% in recent trading Tuesday. Price: 0.15,...

Gogoro Gets $50 Million Investment From Castrol

Jun 25, 2024

10:32 AM EDT, 06/25/2024 (MT Newswires) -- Gogoro ( GGR ) will receive up to $50 million in investment as part of a collaboration with BP (BP) subsidiary Castrol, the companies said Tuesday. Castrol affiliate Castrol Holdings will invest in the two-tranche transaction, which includes $25 million in common shares of Gogoro ( GGR ) followed by a $25 million...

Eli Lilly Teams Up With OpenAI to Develop Antimicrobials for Drug-Resistant Bacteria

Jun 25, 2024

10:36 AM EDT, 06/25/2024 (MT Newswires) -- Eli Lilly ( LLY ) said Tuesday it will collaborate with OpenAI to use generative artificial intelligence technology to develop antimicrobials to treat drug-resistant pathogens. The collaboration backs Lilly's pledge to fight drug-resistant pathogens via its Social Impact Venture Capital Portfolio, the company said. Financial details about the collaboration weren't provided. Price: 898.78,...

Core Scientific Reports New Contract With CoreWeave For Additional Infrastructure

Jun 25, 2024

10:30 AM EDT, 06/25/2024 (MT Newswires) -- Core Scientific ( CORZ ) said Tuesday that CoreWeave has exercised its option to contract for additional infrastructure based on 200 megawatt, 12-year high-performance computing hosting agreement. Core Scientific ( CORZ ) will modify 100 MW of its infrastructure to deliver around 70 MW to host CoreWeave's NVIDIA GPUs for high-performance computing operations,...